{"name": "Molecular Therapeutics",
 "permalink": "molecular-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/molecular-therapeutics",
 "homepage_url": "http://www.moleculartherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "MRx",
 "email_address": "al@moleculartherapeutics.com",
 "phone_number": "734.259.4574",
 "description": "",
 "created_at": "Fri Sep 11 15:27:53 UTC 2009",
 "updated_at": "Fri Sep 11 15:30:11 UTC 2009",
 "overview": "\u003Cp\u003EMolecular Therapeutics, Inc. (MRx) is a privately held biotechnology holding company that focuses on in-licensing promising pharmaceutical and medical device technologies in the late preclinical development phase and conducts proof-of-principle clinical (phase II) studies on a virtual basis for eventual corporate partnership and commercialization.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       103],
      "assets/images/resized/0005/9477/59477v1-max-150x150.png"],
     [[250,
       172],
      "assets/images/resized/0005/9477/59477v1-max-250x250.png"],
     [[253,
       175],
      "assets/images/resized/0005/9477/59477v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Al",
      "last_name": "Rehemtulla",
      "permalink": "al-rehemtulla",
      "image": null}},
   {"is_past": false,
    "title": "   President and Founder",
    "person":
     {"first_name": "Brian",
      "last_name": "D. Ross",
      "permalink": "brian-d-ross",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 12400000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "",
   "source_description": "Cap Funding Report",
   "acquired_year": 2008,
   "acquired_month": 9,
   "acquired_day": 15,
   "acquiring_company":
    {"name": "Charles River Laboratories International",
     "permalink": "charles-river-laboratories-international",
     "image":
      {"available_sizes":
        [[[150,
           44],
          "assets/images/resized/0005/9479/59479v1-max-150x150.png"],
         [[189,
           56],
          "assets/images/resized/0005/9479/59479v1-max-250x250.png"],
         [[189,
           56],
          "assets/images/resized/0005/9479/59479v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": " 800 Technology Drive ",
    "address2": "",
    "zip_code": "48108 ",
    "city": "Ann Arbor",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": 42.2129741,
    "longitude": -83.7431165}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}